Back to BlackRock, Inc. BlackRock, Inc.

TRDATRDA
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ENTRADA THERAPEUTICS INC

BlackRock, Inc. holds 2.6M shares of TRDA (ENTRADA THERAPEUTICS INC), worth $19M as of 2026-Q2. The position was increased (+9.5% shares). TRDA represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$19M

Current Shares

2.6M

Total Value Change

-$15.1M

Total Shares Change

+608,881

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+9.5%
$19M0.0%$7.36
31
2026-Q1
Increased
2.4M
+9.8%
$29.8M0.0%$11.85
32
2025-Q4
Increased
2.1M
+5.0%
$22.1M0.0%$10.09
30
2025-Q3
Increased
2M
+1.1%
$11.9M0.0%$5.84
28
2025-Q2
Increased
2M
+1.6%
$13.6M0.0%$6.91
28
2025-Q1
Increased
2M
+0.8%
$18M0.0%$9.56
28
2024-Q4
New
2M
-
$34.1M0.0%$17.37
40

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used